301 results
Page 3 of 16
DEFA14A
EX-10.1
6fceevtc6bdcbw
1 Aug 22
Additional proxy soliciting materials
6:01am
DEFA14A
EX-99.1
dmu464 n5nna
1 Aug 22
Additional proxy soliciting materials
6:01am
8-K
EX-10.1
mlbfa
29 Jul 22
Synthetic Biologics Announces $3 Million Private Placement of
4:50pm
8-K
EX-99.1
9u31xj2m
29 Jul 22
Synthetic Biologics Announces $3 Million Private Placement of
4:50pm
8-K
EX-99.1
zd97cz
15 Jul 22
Synthetic Biologics Announces Reverse Stock Split
8:06am
8-K
EX-99.1
o0xsxnps05r byxos
16 May 22
Synthetic Biologics Reports First Quarter 2022 Operational Highlights and Financial Results
8:05am
8-K
EX-99.1
v1kbs4ssoxawn
10 May 22
Synthetic Biologics Reports Positive Safety Data on SYN-020 Intestinal Alkaline Phosphatase
9:18am
8-K/A
EX-99.1
q1ptxmv4lx
6 May 22
Completion of Acquisition or Disposition of Assets
5:22pm
8-K/A
EX-99.2
otnpy006 400qu5t5y
6 May 22
Completion of Acquisition or Disposition of Assets
5:22pm
8-K
EX-99.1
qyuhotzwk6hxtmi
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
EX-10.1
2dslt4s4pc zhab
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
f48n1wexsm
23 Mar 22
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
8:30am
8-K
EX-99.1
83o 02537
16 Mar 22
Synthetic Biologics Reports 2021 Year End Operational Highlights and Financial Results
4:15pm
8-K
EX-99.1
eyfaxg
11 Mar 22
Synthetic Biologics Completes Acquisition of VCN Biosciences
8:06am
8-K
EX-99.1
o9a7hz
27 Jan 22
January 2022 B. Riley Securities Oncology Investor Conference
7:01am
8-K
wiifpl
4 Jan 22
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
ts360poyi fs
4 Jan 22
Departure of Directors or Certain Officers
5:21pm